Gene expression dose-response changes in microarrays after exposure of human peripheral lung epithelial cells to nickel(II)

Toxicology and Applied Pharmacology

Volumn 191, Issue 1, 2003, Pages 22-39

  Cheng, Robert Y S ^a   Zhao, Ailian ^a   Alvord, W Gregory ^b   Powell, Douglas A ^b   Bare, Robert M ^a   Masuda, Akira ^c   Takahashi, Takashi ^c   Anderson, Lucy M ^a   Kasprzak, Kazimierz S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Data Management Services Inc   (United States)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Gene expression; Lung cancer; Microarray; Nickel

Indexed keywords

COMPLEMENTARY DNA; DYSKERIN; FERRITIN; HEAT SHOCK PROTEIN; INTERFERON REGULATORY FACTOR 1; METALLOTHIONEIN; NICKEL; PROTEIN DERIVATIVE; PROTEIN RAD21; RHO FACTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CARCINOGENESIS; CELL CULTURE; CELL LINE; CELL MEMBRANE; CONCENTRATION RESPONSE; CYTOTOXICITY; DNA MICROARRAY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOTOXICITY; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; OCCUPATIONAL EXPOSURE; ONCOGENE; PROBABILITY; PROTEIN METABOLISM; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RISK ASSESSMENT; SIGNAL TRANSDUCTION;

EID: 0042564455     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(03)00228-X     Document Type: Article

References (61)

1. Adams L., Scott G.K., Weinberg C.S. Biphasic modulation of cell growth by recombinant human galectin-1. Biochim. Biophys. Acta. 1312:1996;137-144.
2. Afshari C.A., Nuwaysir E.F., Barrett C.J. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. Cancer Res. 59:1999;4759-4760.
3. Andrew A.S., Warren A.J., Temle K.A., Hamilton J.W. Differential effects of arsenic, chromium, cadmium, nickel and mitomycin C on gene expression as measured by DNA microarray. Toxicologist. 66:2002;116.
4. Ayesh S., Matouk I., Schneider T., Ohana P., Laster M., Al-Sharef W., De-Groot N., Hochberg A. Possible physiological role of H19 RNA. Mol. Carcinog. 35:2002;63-74.
5. Bauman J.W., Klaassen C.D. Production of metallothionein and heat-shock proteins in response to metals. Fundaml. Appl. Toxicol. 21:1993;15-22.
6. Berberat P.O., Friess H., Wang L., Zhu Z., Bley T., Frigeri L., Zimmermann A., Buchler M.W. Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer. J. Histochem. Cytochem. 49:2001;539-549.
7. Buckhaults P., Rago C., St. Croix B., Romans K.E., Saha S., Zhang L., Vogelstein B., Kinzler K.W. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res. 61:2001;6996-7001.
8. Bui K.C., Buckley S., Wu F., Uhal B., Joshi I., Liu J., Hussain M., Makhoul I., Warburton D. Induction of A- and D-type cyclins and cdc2 kinase activity during recovery from short-term hyperoxic lung injury. Am. J. Physiol. 268:1995;L625-635.
9. Burczynski M.E., McMillian M., Ciervo J., Li L., Parker J.B., Dunner R.T., Hicken S., Farr S., Johnson M.D. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol. Sci. 58:2000;399-415.
10. Chang J.W., Jeon H.B., Lee J.H., Yoo J.S., Chun J.S., Kim J.H., Yoo Y.J. Augmented expression of peroxiredoxin I in lung cancer. Biochem. Biophys. Res. Commun. 289:2001;507-512.
11. Diehn M., Sherlock G., Binkley G., Jin H., Matese J.C., Hernandez-Boussard T., Rees C.A., Cherry J.M., Botstein D., Brown P.O., Alizadeh A.A. SOURCE a unified genomic resource of functional annotations, ontologies, and gene expression data . Nucleic Acids Res. 31:2003;219-223.
12. Dillon W.R., Goldstein M. Multivariate Analysis - Methods and Applications. 1984;Wiley, New York.
13. Fritz P., Seizer-Schmidt R., Murdter T.E., Kroemer H.K., Aulitzky W., Andre S., Gabius H.J., Friedel G., Toomes H., Siegle I. Ligands for Viscum album and galectin-1 in human lung cancer is there any prognostic relevance? Acta Histochem. 101:1999;239-253.
14. Furthauer M., Reifers F., Brand M., Thisse B., Thisse C. Sprouty4 acts in vivo as a feedback-induced antagonist of FGF signaling in zebrafish. Development. 128:2001;2175-2186.
15. Fusco C., Reymond A., Zervos A.S. Molecular cloning and characterization of a novel retinoblastoma-binding protein. Genomics. 51:1998;351-358.
16. Ganger D.R., Hamilton P.D., Klos D.J., Jakate S., McChesney L., Fernandez-Pol J.A. Differential expression of metallopanstimulin/S27 ribosomal protein in hepatic regeneration and neoplasia. Cancer Detect. Prev. 25:2001;231-236.
17. Gerhold D., Lu M., Xu J., Austin C., Caskey C.T., Rushmore T. Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiol. Genomics. 27:2001;161-170.
18. Haber L.T., Erdreicht L., Diamond G.L., Maier A.M., Ratney R., Zhao Q., Dourson M.L. Hazard identification and dose of inhaled nickel-soluble salts. Regul. Toxicol. Pharmacol. 31:2000;210-230.
19. Heck D.E., Roy A., Laskin J.D. Nucleic acid microarray technology for toxicology promise and practicalities . Adv. Exp. Med. Biol. 500:2001;709-714.
20. Kasprzak K.S. Oxidative DNA damage in metal-induced carcinogenesis. Chang L.W. Toxicology of Metals. 1996;299-320 CRC Lew, Boca Raton, FL.
21. Kaufman L., Rousseeuw P.J. Finding Groups in Data-An Introduction to Cluster Analysis. 1990;Wiley, New York.
22. Kita H., Carmichael J., Swartz J., Muro S., Wyttenbach A., Matsubara K., Rubinsztein D.C., Kato K. Modulation of polyglutamine-induced cell death by genes identified by expression profiling. Hum. Mol. Genet. 11:2002;2279-2287.
23. Kohonen T. Self-Organizing Maps. third ed: 2001;Springer, New York.
24. Lee Y.W., Klein C.B., Kargacin B., Salnikow K., Kitahara J., Dowjat K., Zhitkovich A., Christie N.T., Costa M. Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation a new model for epigenetic carcinogens . Mol. Cell Biol. 15:1995;2547-2557.
25. Lee S.H., Shaio Y.H., Plisov S.Y., Kasprzak K.S. Nickel(II) acetate-treated Chinese hamster ovary cells differentially express Vimentin, hSNF2H homologue, and H ferritin. Biochem. Biophys. Res. Commun. 258:1999;592-595.
26. Leikauf G.D., McDowell S.A., Wesselkamper S.C., Miller C.R., Hardie W.D., Gammon K., Biswas P.P., Korfhagen T.R., Bachurski C.J., Wiest J.S., Willeke K., Bingham E., Leikauf J.E., Aronow B.J., Prows D.R. Pathogenomic mechanisms for particulate matter induction of acute lung injury and inflammation in mice. Res. Rep. Health Effects Inst. 105:2001;5-71.
27. Liu G.X., Sheng H.F., Wu S. A study on the levels of calmodulin and DNA in human lung cancer cells. Br. J. Cancer. 73:1996;899-901.
28. Lottin S., Adriaenssens E., Dupressoir T., Berteaux N., Montpellier C., Coll J., Dugimont T., Curgy J.J. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis. 23:2002;1885-1895.
29. Masuda A., Kondo M., Saito T., Yatabe Y., Kobayashi T., Okamoto M., Suyama M., Takahashi T., Takahashi T. Establishment of human peripheral lung epithelial cell lines (HPL 1) retaining differentiated characteristics and responsiveness to epidermal growth factor, hepatocyte growth factor, and transforming growth factor β1. Cancer Res. 57:1997;4898-4904.
30. McDowell S.A., Gammon K., Bachurski C.J., Wiest J.S., Leikauf J.E., Prows D.R., Leikauf G.D. Differential gene expression in the initiation and progression of nickel-induced acute lung injury. Am. J. Respir. Cell Mol. Biol. 23:2000;466-474.
31. Milman N., Pedersen L.M. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer. Oncol. Rep. 9:2002;193-198.
32. Park J.S., Arcaroli J., Yum H.K., Yang H., Wang H., Yang K.Y., Choe K.H., Strassheim D., Pitts T.M., Tracey K.J., Abraham E. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Cell Physiol. 284:2003;C870-879.
33. Pati D., Zhang N., Plon S.E. Linking sister chromatid cohesion and apoptosis role of Rad21 . Mol. Cell Biol. 22:2002;8267-8277.
34. Paz A., Haklai R., Elad-Sfadia G., Ballan E., Kloog Y. Galectin-1 binds oncogenic H-ras to mediate Ras membrane anchorage and cell transformation. Oncogene. 20:2001;7486-7493.
35. Pogacic V., Dragon F., Filipowicz W. Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol. Cell Biol. 20:2000;9028-9040.
36. Poser I., Golob M., Buettner R., Bosserhoff A.K. Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. Mol. Cell Biol. 23:2003;2991-2998.
37. Raos N., Kasprzak K.S. Effect of nickel(II) acetate on distribution of calmodulin in the rat kidney. Toxicol. Lett. 48:1989;275-282.
38. Raos N., Kasprzak K.S. Allosteric binding of nickel(II) to calmodulin. Fundam. Appl. Toxicol. 13:1989;816-822.
39. Rebhan M., Chalifa-Caspi V., Prilusky J., Lancet D. GeneCards encyclopedia for genes, proteins, and databases . 1997;Weizmann Institute of Science, Bioinformatics Unit and Genome Center, Rehovot, Israel.
40. Ruggero D., Grisendi S., Piazza F., Rego E., Mari F., Rao P.H., Cordon-Cardo D., Pandolfi P.P. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science. 299:2003;259-262.
41. Russo G., Ricciardelli G., Pietropaolo C. Different domains cooperate to target the human ribosomal L7a protein to the nucleus and to the nucleoli. J. Biol. Chem. 272:1997;5229-5235.
42. Salnikow K., An W.G., Melillo G., Blagosklonny M.V., Costa M. Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors. Carcinogenesis. 20:1999;1819-1823.
43. Salnikow K., Blagosklonny M.V., Ryan H., Johnson R., Costa M. Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res. 60:2000;38-41.
44. Salnikow K., Su W., Blagosklonny M.V., Costa M. Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res. 60:2000;3375-3378.
45. Salnikow K., Costa M. Epigenetic mechanisms of nickel carcinogenesis. J. Environ. Pathol. Toxicol. 19:2000;307-318.
46. Shimizu K., Nagamachi Y., Tani M., Kimura K., Shiroishi T., Wakana S., Yokota J. Molecular cloning of a novel NF2/ERM/4.1 superfamily gene, ehm2, that is expressed in high-metastatic K1735 murine melanoma cells. Genomics. 65:2000;113-120.
47. Skonier J., Neubauer M., Madisen L., Bennett K., Plowman G.D., Purchio A.F. cDNA cloning and sequence analysis of beta ig-h3, novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol. 11:1992;511-522.
48. Sun S.Y., Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Crit. Rev. Oncol. Hematol. 41:2002;41-55.
49. Sunderman F.W. Search for molecular mechanisms in the genotoxicity of nickel. Scand. J. Work Environ. Health. 19:(Suppl. 1):1993;75-80.
50. Sunil V.R., Connor A.J., Guo J., Laskin J.D., Laskin D.L. Activation of type II alveolar epithelial cells curing acute endotoxemia. Am. J. Physiol. 282:2002;L872-880.
51. Torok K., Wilding M., Groigno L., Patel R., Whitaker M. Imaging the spatial dynamics of calmodulin activation during mitosis. Curr. Biol. 8:1998;692-699.
52. Tufan N.L., Lian Z., Liu J., Pan J., Arbuthnot P., Kew M., Clayton M.M., Zhu M., Feitelson M.A. Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival. Neoplasia. 4:2002;355-368.
53. Van den Brule F.A., Waltregny D., Castronova V. Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients. J. Pathol. 193:2001;80-87.
54. Wang J.F., Bashir M., Engelsberg B.N., Witmer C., Rozmiarek H., Billings P.C. High mobility group proteins 1 and 2 recognize chromium-damaged DNA. Carcinogenesis. 18:1997;371-375.
55. Wang Y., Cheong D., Chan S., Hooi S.C. Ribosomal protein L7a is up-regulated but not fused to the tyrosine kinase receptor as chimeric trk oncogene in human colorectal carcinoma. Int. J. Oncol. 16:2000;757-762.
56. Waring J.F., Jolly R.A., Ciurlionis R., Lum P.Y., Praestgaard J.T., Morfitt D.C., Buratto B., Roberts C., Schadt E., Ulrich R.G. Clustering of hepatotoxins based on the mechanism of toxicity using gene expression profiles. Toxicol. Appl. Pharmacol. 175:2001;28-42.
57. Wei W., Dorjsuren D., Lin Y., Qin W., Nomura T., Hayashi N., Murakami S. Direct interaction between the subunit RAP30 of transcription factor IIF and RNA polymerase subunit 5, which contributes to the association between TFIIF and RNA polymerase II. J. Biol. Chem. 276:2001;12266-12273.
58. Wells V., Mallucci L. Identification of an autocrine negative growth factor mouse beta-galactoside-binding protein is a cytostatic factor and cell growth regulator . Cell. 64:1991;91-97.
59. Wu F., Buckley S., Bui K.C., Warburton D. Differential expression of cyclin D2 and cdc2 genes in proliferating and nonproliferating alveolar epithelial cells. Am. J. Respir. Cell. Mol. Biol. 12:1995;95-103.
60. Yoneda K., Peck K., Chang M.M., Chmiel K., Sher Y.P., Chen J., Yang P.C., Chen Y., Wu R. Development of high-density DNA microarray membrane for profiling smoke- and hydrogen peroxide-induced genes in a human bronchial epithelial cell line. Am. J. Respir. Crit. Care Med. 164:2001;S85-89.
61. Zohn I.M., Campbell S.L., Khosravi-Far R., Rossman K.L., Der C.J. Rho family proteins and Ras transformation the RHOad less traveled gets congested. Oncogene. 17:1998;1415-1438.